The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Zuerblis Kenneth J since year 2005.
The trader's CIK number is 1007923.
At the time of this reporting, Zuerblis Kenneth J is the Director of Stemline Therapeutics Inc .
(stock ticker symbol STML).
See this page for all insider trading activities at Stemline Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-09-02||STML||Stemline Therapeutics Inc||Buy||1,000||11.14||11,143|
|2013-05-30||STML||Stemline Therapeutics Inc||Buy||900||16.38||14,742|
|2013-05-29||STML||Stemline Therapeutics Inc||Buy||2,100||15.86||33,299|
|2011-12-07||IMMU||Immunomedics Inc||Option Ex||5,000||.00||0|
|2011-11-18||SVNT||Savient Pharmaceuticals Inc||Buy||2,000||2.34||4,690|
|2011-09-15||SVNT||Savient Pharmaceuticals Inc||Buy||4,000||4.05||16,187|
|2011-09-14||SVNT||Savient Pharmaceuticals Inc||Buy||1,000||3.97||3,970|
|2010-12-01||IMMU||Immunomedics Inc||Option Ex||4,167||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zuerblis Kenneth J (Director of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.